Russell Investments Group, Ltd. Coherus Bio Sciences, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$1.58 - $2.51 $115,268 - $183,117	72,955 New	72,955 $126,000
Q4 2023 Feb 05, 2024	BUY	$1.59 - $3.85 $116,232 - $281,442	73,102 New	73,102 $243,000
Q2 2023 Aug 10, 2023	SELL	$3.79 - $8.3 $328,574 - $719,568	-86,695 Reduced 98.69%	1,155 $4,000
Q1 2023 May 09, 2023	SELL	$5.89 - $10.52 $15,573 - $27,814	-2,644 Reduced 2.92%	87,850 $600,000
Q4 2022 Feb 08, 2023	BUY	$5.69 - $10.07 $46,322 - $81,979	8,141 Added 9.89%	90,494 $716,000
Q3 2022 Nov 04, 2022	SELL	$7.17 - $13.87 $184,190 - $356,306	-25,689 Reduced 23.78%	82,353 $789,000
Q2 2022 Jul 29, 2022	BUY	$5.86 - $13.23 $507,136 - $1.14 Million	86,542 Added 402.52%	108,042 $781,000
Q1 2022 May 05, 2022	BUY	$10.92 - $16.41 $234,780 - $352,815	21,500 New	21,500 $277,000
Q2 2021 Aug 04, 2021	SELL	$12.95 - $15.41 $861,628 - $1.03 Million	-66,535 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$14.42 - $21.39 $350,636 - $520,119	-24,316 Reduced 26.76%	66,535 $971,000
Q4 2020 Feb 08, 2021	BUY	$16.56 - $18.94 $416,798 - $476,700	25,169 Added 38.32%	90,851 $1.58 Million
Q3 2020 Nov 09, 2020	BUY	$17.41 - $19.89 $250,582 - $286,276	14,393 Added 28.06%	65,682 $1.2 Million
Q2 2020 Aug 05, 2020	SELL	$14.43 - $19.16 $151,038 - $200,547	-10,467 Reduced 16.95%	51,289 $915,000
Q1 2020 May 06, 2020	BUY	$11.67 - $22.53 $291,236 - $562,258	24,956 Added 67.82%	61,756 $1 Million
Q4 2019 Jan 29, 2020	SELL	$16.33 - $21.37 $1.03 Million - $1.35 Million	-63,204 Reduced 63.2%	36,800 $662,000
Q3 2019 Nov 01, 2019	BUY	$16.3 - $23.37 $1.63 Million - $2.34 Million	100,004 New	100,004 $2.03 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account